Nonalcoholic fatty liver disease among HIV-infected persons. - Wikidata - wikimedia - TriplyDB

Nonalcoholic fatty liver disease among HIV-infected persons.

Nonalcoholic fatty liver disease among HIV-infected persons.

http://www.wikidata.org/entity/Q37434578

about

Role of liver transplantation in human immunodeficiency virus positive patients Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV Tuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South Africa Association of Abnormal Liver Function Parameters with HIV Serostatus and CD4 Count in Antiretroviral-Naive Rwandan Women.The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).Liver disease, HIV and aging.Risk factors for fatty liver in the Multicenter AIDS Cohort Study.Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects.Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men.Liver disease in the HIV-infected individual.Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV.Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy.Viral mechanisms of adipose dysfunction: lessons from HIV-1 Vpr Human immunodeficiency virus infection and the liver Secondary causes of nonalcoholic fatty liver disease.Elevated alanine aminotransferase in antiretroviral-naïve HIV-infected African patients: magnitude and risk factors.Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected Adults Human immunodeficiency virus and liver disease: An update.Lipolytic Rate Associated With Intramyocardial Lipid in an HIV Cohort Without Increased Lipolysis.Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection Role of mitochondria in HIV infection and associated metabolic disorders: focus on nonalcoholic fatty liver disease and lipodystrophy syndrome.Liver steatosis in Chinese HIV-infected patients with hypertriglyceridemia: characteristics and independent risk factors Traditional but not HIV-related factors are associated with nonalcoholic fatty liver disease in Asian patients with HIV-1 infection.BL153 partially prevents high-fat diet induced liver damage probably via inhibition of lipid accumulation, inflammation, and oxidative stress.Treatment of dyslipidemia in HIV-infected patients.The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV.Treatment of dyslipidemia in HIV.Novel Approaches to Targeting Visceral and Hepatic Adiposities in HIV-Associated Lipodystrophy.Liver involvement in human immunodeficiency virus infection.Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir.Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV.Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV.

P2860

Q26775931-EE324EE3-F4EF-4BF6-8AD8-B7C0DF2C068C Q26798157-7E26EEA3-5A42-47D0-93D3-C55039080AD0 Q28079826-1C029DEB-228B-4E39-9672-90CFD9F03DFB Q28543376-318973D8-7A49-4E3F-B5D1-C674CC320B17 Q30387567-E21DF8E8-A1B4-46E6-9CD4-8241D0550114 Q30497534-BFDB1F04-FA73-40F0-919B-6BB65817D96E Q31050092-772618C3-71F9-4702-9AB5-6D27FBA3254D Q31149395-3EB0AA18-E0C7-4E52-ACA1-F4E49C24776E Q33621724-6EE1D3BF-936C-4EC9-9504-BA6E2D790E81 Q33778556-45403539-DD1B-448C-9CA0-14390BBFE0D5 Q33810577-39924F2B-EE29-4365-89B5-A90B5B5CF49C Q34049896-85E28640-BC9C-412A-A14E-435F688F99C1 Q34157953-C5E09F2B-88BF-43A7-BDF3-B0891E77922E Q34227450-95288703-A6E3-4A1F-9E60-1D4D1B846385 Q34380326-4D6EBF04-5D1E-48E1-8C97-D11987AFB6EA Q34852032-045FA710-7BCC-4C9D-82A9-5D2F450FA9B3 Q35186541-3D4A6340-5ECB-4866-99B8-7AD9AE285B78 Q35588143-E2A27EAB-A279-4180-BA1A-444538E13A96 Q35834850-28476FE2-2A41-45B1-8B01-CECE7A6BD15F Q35875848-93E6D88E-B999-43C3-85AB-9247344C7A9F Q35929072-CA859909-A6F4-4D9C-B517-BCE04236C9FD Q36080888-77533245-65DC-4E3C-ABCD-7B71787A6B86 Q36158019-734ADE84-1C3A-4781-9A85-4A966F0CC722 Q36208623-B24C2938-E42B-4288-9FE3-113EADB414EC Q36378109-9783129A-E91C-4670-ABCB-D6578A56B670 Q36431659-32CB9E8B-6746-4AEC-A74C-32173C94607A Q36532400-D30E656D-6AC2-4305-9501-D01BF07BE204 Q37056681-5DD33DE5-2F7C-4F61-89BD-44174FA0947F Q37077573-9424FA4E-A65D-4773-8387-DB96101162C7 Q37152712-5BC84065-675C-45EE-9725-B42A5547A109 Q37539083-3619AB2E-F297-4E11-8243-573C9D449C54 Q37719108-57CC2510-2846-443F-A509-11C07BED7A48 Q37756963-0A833940-FA04-49B8-AA4B-D727FE66B5D3 Q37807885-3E8C6E9E-503A-490A-A87A-FBF7C5FE8574 Q38363531-1439C6CA-C146-4729-BE02-A58993622BFF Q38614025-CD642481-A052-4365-9B42-54167B24EEF5 Q38852184-4B048A16-06D7-403D-BCA1-39A25247970A Q38915274-D7B4C6C1-1EEC-417F-AD0E-7D18F3398944 Q38916843-95D4F011-8EB1-418F-8B61-0F97FFF27227 Q39173801-C78C89BB-EEBF-4E7E-B433-BAE128CD0D0F

P2860

Nonalcoholic fatty liver disease among HIV-infected persons.

http://www.wikidata.org/entity/Q37434578

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nonalcoholic fatty liver disease among HIV-infected persons.

@en

Nonalcoholic fatty liver disease among HIV-infected persons.

@nl

type

label

Nonalcoholic fatty liver disease among HIV-infected persons.

@en

Nonalcoholic fatty liver disease among HIV-infected persons.

@nl

prefLabel

Nonalcoholic fatty liver disease among HIV-infected persons.

@en

Nonalcoholic fatty liver disease among HIV-infected persons.

@nl

P1433

Q37434578-20909246-B17A-472C-A5DA-F6F79E46AA31

P1476

Q37434578-EE7E08C5-5776-4A76-80D8-B188C743A30F

P2093

Q37434578-02D73CCC-EFE0-4870-B17C-0E402B9DAF48

Q37434578-23A28854-C4D6-4AB5-B9F2-181DEC86FDC1

Q37434578-33877813-1CC8-40D7-8EF1-2F30765E513C

Q37434578-3D1B1E06-7B8B-4680-8803-78E7FC9AF06E

Q37434578-49EB117E-F8CA-4455-9CC7-58CF055B7BAC

Q37434578-7634B961-444D-4F2A-9FDC-87A8BCD12390

Q37434578-7C34B3EB-16DE-4FFB-8AA8-336563DC0141

Q37434578-91A55CFC-E2B3-44ED-BFB8-B867D4FBEF89

Q37434578-C373A8CB-C391-4414-BDEC-97070B7934B0

Q37434578-CC56CC2E-2D22-415C-B242-5230104DEFB6

P2860

Q37434578-01E001E5-A35E-48CB-B573-80E78F4F0291

Q37434578-10753218-89F7-4E8D-A44B-4D04608A49CB

Q37434578-176FB11E-4240-4A5B-9E6F-FDA8859F3E67

Q37434578-1B2B0599-1F58-4280-923F-A12D7910A164

Q37434578-1B58A9BA-1752-4603-A3C6-1E52151663F0

Q37434578-1CD53F15-15A6-43C6-B98E-8B60DBF823B4

Q37434578-22A358A2-AFC7-48D6-BFDD-223BD175EEB1

Q37434578-26F38EA5-8EFC-4C4D-9486-9F42816B7F2E

Q37434578-2B23C204-6272-4C9F-9C6D-DF40A6A856A4

Q37434578-2C509658-07AA-4CA3-B6B9-F7B4CB323ACF

P304

Q37434578-3FA2A7CF-6AE3-4564-924F-D15E2DA8D286

P31

Q37434578-A160829E-E28C-4EFA-8666-694DCAFF7C12

P356

Q37434578-63E358F3-6802-4B2B-B65A-064F3C124B12

P407

Q37434578-13DDE35D-D7F6-4748-90DD-49601F4F99D7

P433

Q37434578-2789223E-E5DA-49F9-AF14-04A49BEAFB89

P478

Q37434578-6DA1E6DF-DC12-4BB7-AC47-0A4838966C93

P577

Q37434578-3C4ACC23-87F2-4536-81AE-E4C24184A759

P698

Q37434578-7E653C58-9DC0-4D5D-BC6D-ECA7245271D2

P921

Q37434578-F6E29179-511D-489E-A826-8075663DD4A2

P932

Q37434578-F625FEA1-1D75-4BED-A11E-1F0AACBFBC47

P356

QAI.0B013E318198A88A

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Nonalcoholic fatty liver disease among HIV-infected persons.

@en

P2093

Alan Lifson

http://www.w3.org/2001/XMLSchema#string

Angelica Dilay

http://www.w3.org/2001/XMLSchema#string

Braden Hale

http://www.w3.org/2001/XMLSchema#string

Charles Hames

http://www.w3.org/2001/XMLSchema#string

Dean Asher

http://www.w3.org/2001/XMLSchema#string

Gary Collins

http://www.w3.org/2001/XMLSchema#string

Mary Bavaro

http://www.w3.org/2001/XMLSchema#string

Nancy Crum-Cianflone

http://www.w3.org/2001/XMLSchema#string

Richard Campin

http://www.w3.org/2001/XMLSchema#string

Robin Parker

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

Prevalence of overweight and obesity in the United States, 1999-2004

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

Steatohepatitis: a tale of two "hits"?

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

Histological grading and staging of chronic hepatitis

P304

464-473

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0B013E318198A88A

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19225402

http://www.w3.org/2001/XMLSchema#string

P921

P932

2782375

http://www.w3.org/2001/XMLSchema#string